Kwality Pharmaceuticals Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 39.80 | 32.50 | 41.60 | -- |
| Op profit growth | 32.10 | 76.70 | 53.20 | -- |
| EBIT growth | 26 | 105 | 54.60 | -- |
| Net profit growth | 35.10 | 116 | 69.50 | -- |
| Profitability ratios (%) | ||||
| OPM | 8.48 | 8.98 | 6.73 | 6.22 |
| EBIT margin | 6.90 | 7.65 | 4.94 | 4.53 |
| Net profit margin | 3.31 | 3.42 | 2.09 | 1.75 |
| RoCE | 18.90 | 19 | 11.90 | -- |
| RoNW | 4.11 | 3.55 | 1.90 | -- |
| RoA | 2.27 | 2.12 | 1.26 | -- |
| Per share ratios () | ||||
| EPS | 4.26 | 6.32 | 2.56 | 1.82 |
| Dividend per share | -- | 0.60 | -- | -- |
| Cash EPS | 1.51 | 1.65 | (0.30) | (0.80) |
| Book value per share | 28.70 | 49.30 | 43.40 | 38.40 |
| Valuation ratios | ||||
| P/E | 9.62 | 7.59 | -- | -- |
| P/CEPS | 27.10 | 29.10 | -- | -- |
| P/B | 1.43 | 0.97 | -- | -- |
| EV/EBIDTA | 5.41 | 6.57 | -- | -- |
| Payout (%) | ||||
| Dividend payout | -- | 11 | -- | -- |
| Tax payout | (39) | (42) | (48) | (41) |
| Liquidity ratios | ||||
| Debtor days | 79.20 | 75.40 | 66.60 | -- |
| Inventory days | 38.30 | 44.90 | 41.40 | -- |
| Creditor days | (51) | (46) | (37) | -- |
| Leverage ratios | ||||
| Interest coverage | (4.30) | (4) | (3.10) | (2.30) |
| Net debt / equity | 0.83 | 0.63 | 0.53 | 0.36 |
| Net debt / op. profit | 2.13 | 1.82 | 2.31 | 2.10 |
| Cost breakup () | ||||
| Material costs | (74) | (72) | (76) | (73) |
| Employee costs | (4.10) | (4.30) | (3.60) | (3.90) |
| Other costs | (14) | (14) | (14) | (16) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Revenue | 139 | 137 | 98.30 | 74.20 |
| yoy growth (%) | 1.31 | 39.80 | 32.50 | 41.60 |
| Raw materials | (87) | (101) | (71) | (56) |
| As % of sales | 62.50 | 73.70 | 72.40 | 75.70 |
| Employee costs | (12) | (5.60) | (4.20) | (2.70) |
| As % of sales | 8.57 | 4.08 | 4.30 | 3.59 |
| Other costs | (26) | (19) | (14) | (10) |
| As % of sales | 18.70 | 13.80 | 14.30 | 14 |
| Operating profit | 14.20 | 11.70 | 8.82 | 4.99 |
| OPM | 10.20 | 8.48 | 8.98 | 6.73 |
| Depreciation | (4.40) | (3) | (2.50) | (1.70) |
| Interest expense | (2.50) | (2.20) | (1.90) | (1.20) |
| Other income | 3.66 | 0.80 | 1.21 | 0.36 |
| Profit before tax | 10.90 | 7.30 | 5.65 | 2.48 |
| Taxes | (2.70) | (2.90) | (2.40) | (1.20) |
| Tax rate | (25) | (39) | (42) | (48) |
| Minorities and other | 0.11 | 0.12 | 0.09 | 0.27 |
| Adj. profit | 8.32 | 4.55 | 3.36 | 1.55 |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 8.32 | 4.55 | 3.36 | 1.55 |
| yoy growth (%) | 82.90 | 35.10 | 116 | 69.50 |
| NPM | 5.97 | 3.31 | 3.42 | 2.09 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Profit before tax | 7.30 | 5.65 | 2.48 | 1.35 |
| Depreciation | (3) | (2.50) | (1.70) | (1.30) |
| Tax paid | (2.90) | (2.40) | (1.20) | (0.50) |
| Working capital | 16.90 | 4.27 | (4.30) | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 18.40 | 5.04 | (4.70) | -- |
| Capital expenditure | 13.10 | 6.79 | (6.80) | -- |
| Free cash flow | 31.50 | 11.80 | (11) | -- |
| Equity raised | 35.60 | 34.30 | 35.40 | -- |
| Investments | 4.34 | 1.71 | (1.70) | -- |
| Debt financing/disposal | 20.50 | 7.61 | (3.80) | -- |
| Dividends paid | -- | 0.31 | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 91.90 | 55.70 | 18.40 | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Equity capital | 10.40 | 10.40 | 5.19 | 5.01 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 26.90 | 19.40 | 20.40 | 16.80 |
| Net worth | 37.30 | 29.80 | 25.60 | 21.80 |
| Minority interest | ||||
| Debt | 28.70 | 26.50 | 19.10 | 12.90 |
| Deferred tax liabilities (net) | 0.21 | 0.40 | 0.45 | 0.52 |
| Total liabilities | 65.30 | 55.60 | 44.60 | 34.80 |
| Fixed assets | 29.10 | 20.40 | 17 | 12.70 |
| Intangible assets | ||||
| Investments | 4.82 | 5.34 | 3.65 | 1.94 |
| Deferred tax asset (net) | 0.09 | 0.19 | 0.05 | 0.07 |
| Net working capital | 29.90 | 28.10 | 20.90 | 18.70 |
| Inventories | 11.30 | 15 | 13.90 | 10.40 |
| Inventory Days | -- | 39.90 | 51.40 | 50.90 |
| Sundry debtors | 38.40 | 37 | 22.60 | 18 |
| Debtor days | -- | 98.30 | 83.90 | 88.70 |
| Other current assets | 20.40 | 16.80 | 10.80 | 6.82 |
| Sundry creditors | (17) | (22) | (13) | (9.70) |
| Creditor days | -- | 58.80 | 47.30 | 47.60 |
| Other current liabilities | (23) | (19) | (14) | (6.90) |
| Cash | 1.40 | 1.61 | 2.99 | 1.35 |
| Total assets | 65.30 | 55.60 | 44.60 | 34.80 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Sep-2020 | Mar-2020 | Sep-2019 | Mar-2019 | Sep-2018 |
|---|---|---|---|---|---|
| Gross Sales | 120 | 66.70 | 72.60 | 94.60 | 71.70 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 120 | 66.70 | 72.60 | 94.60 | 71.70 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.46 | 3.31 | 0.35 | 0.19 | 0.42 |
| Total Income | 120 | 70 | 72.90 | 94.80 | 72.10 |
| Total Expenditure ** | 106 | 60.90 | 64.20 | 85.80 | 64.80 |
| PBIDT | 13.80 | 9.12 | 8.73 | 8.98 | 7.34 |
| Interest | 1.20 | 1.08 | 1.42 | 1.11 | 1.17 |
| PBDT | 12.60 | 8.04 | 7.31 | 7.86 | 6.17 |
| Depreciation | 2.97 | 2.59 | 1.85 | 1.66 | 1.46 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 2.71 | 1.71 | 1.32 | 2.24 | 1.20 |
| Deferred Tax | 0.14 | (0.30) | (0.10) | (0.10) | -- |
| Reported Profit After Tax | 6.74 | 4 | 4.20 | 4.01 | 3.54 |
| Minority Interest After NP | (0.20) | (0.10) | (0.10) | 0.08 | (0.10) |
| Net Profit after Minority Interest | 6.95 | 4.06 | 4.25 | 3.94 | 3.62 |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | 6.95 | 4.06 | 4.25 | 3.94 | 3.62 |
| EPS (Unit Curr.) | 6.70 | 3.92 | 4.10 | 3.79 | 3.49 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 10.40 | 10.40 | 10.40 | 10.40 | 10.40 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 11.50 | 13.70 | 12 | 9.49 | 10.20 |
| PBDTM(%) | -- | -- | -- | -- | -- |
| PATM(%) | 5.63 | 6 | 5.79 | 4.24 | 4.94 |